MedTrace Logo

NGS in the Diagnosis of Neonatal Diseases

NCT05476055 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1800

Last updated 2022-07-27

No results posted yet for this study

Summary

To investigate the application of NGS in neonatal disease screening and diagnosis, two studies was conducted (the other ID is: shercru-20220003). This study is to evaluate the application of NGS in the diagnosis of neonatal disease.

Conditions

  • NICU Infants
  • Conventional NBS-positive Infants
  • Premature Infants

Interventions

GENETIC

NGS

In the conbentional NBS+/NICU/premature infants, NGS was conducted to investigate whether NGS can accelerate diagnosis and improve prognosis in these children

Sponsors & Collaborators

  • Children's Hospital of Chongqing Medical University

    collaborator OTHER

  • Xuzhou maternal and Child Health Care Hospital

    collaborator UNKNOWN

  • Shanghai Children's Hospital

    lead OTHER

Principal Investigators

  • Lin Zou · Shanghai Children's Hospital

Eligibility

Min Age
1 Day
Max Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-31
Primary Completion
2024-08-31
Completion
2024-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05476055 on ClinicalTrials.gov